programme is part of CG-AGE, a collaborative project between the Department of Medicine and GlaxoSmithKline, focused on the...
GSK Barnard Castle is a key secondary manufacturing site with advanced manufacturing capability supporting sustained product supply, technical transfers, and new product introductions. As part of our continued focus on growth and performanc...
Director, Government Affairs and Advocacy – Europe and International ViiV About ViiV We are a specialist pharmaceutical company 100% dedicated to developing medicines to treat and prevent HIV. As the pioneers in HIV innovation, we const...
At GSK, we unite science, technology and talent to get ahead of disease together. We are looking for an experienced and strategic HR Business Partner to join our Global Human Resources team, supporting our Development Operations organisatio...
ViiV HR Business Leader The posting period will end on the 29th of July in 2026 Business Introduction: ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines fo...
GSK is in an exciting next phase of performance with three clear priorities – deliver growth, accelerate R&D and simplify how we work. Internal Communications plays a key role in engaging our people to achieve the opportunity we have ahead ...
Interventional Study Scientist Medical Director Locations – GSK HQ UK, New Oxford Street & USA - Upper Providence/ Waltham MA Reports to: Head of Interventional & Supported Studies Join GSK's Medical Affairs team and be part of a glob...
The Capital Projects Engineering Manager provides single-point leadership and accountability for the capital projects engineering team and the end-to-end capital project process across the Barnard Castle manufacturing site. This role repo...
Product Director, Pattern & AI Driven Automation Fixed Term Contract - 18 Months. GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existi...
GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the he...